The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part V. A normative study of the neuropsychological battery.

PubWeight™: 5.81‹?› | Rank: Top 1%

🔗 View Article (PMID 8164812)

Published in Neurology on April 01, 1994

Authors

K A Welsh1, N Butters, R C Mohs, D Beekly, S Edland, G Fillenbaum, A Heyman

Author Affiliations

1: Bryan Alzheimer's Disease Research Center, Duke University Medical Center, Durham, NC 27705.

Associated clinical trials:

Stroke Prevention in the Wisconsin Native American Population | NCT04382963

Computerized Virtual Reality in Elderly | NCT04984694

Articles citing this

(truncated to the top 100)

Amyloid deposition begins in the striatum of presenilin-1 mutation carriers from two unrelated pedigrees. J Neurosci (2007) 3.91

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study. Eur J Nucl Med Mol Imaging (2003) 3.50

Implementing a screening and diagnosis program for dementia in primary care. J Gen Intern Med (2005) 3.26

Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study. Am J Epidemiol (2007) 2.70

Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology (2002) 2.35

The Nun study: clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology (2009) 2.33

Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. Arch Neurol (2009) 2.26

MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology (2001) 2.11

Cognitive deficits in chronic heart failure. Nurs Res (2010) 2.10

Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc (2010) 2.03

CR1 is associated with amyloid plaque burden and age-related cognitive decline. Ann Neurol (2011) 2.02

Consortium to Establish a Registry for Alzheimer's Disease (CERAD): the first twenty years. Alzheimers Dement (2008) 1.90

Basal cerebral metabolism may modulate the cognitive effects of Abeta in mild cognitive impairment: an example of brain reserve. J Neurosci (2009) 1.89

Effectiveness of a lifestyle intervention in promoting the well-being of independently living older people: results of the Well Elderly 2 Randomised Controlled Trial. J Epidemiol Community Health (2011) 1.77

Converging genetic and functional brain imaging evidence links neuronal excitability to working memory, psychiatric disease, and brain activity. Neuron (2014) 1.70

Kidney dysfunction and cognitive decline in women. Clin J Am Soc Nephrol (2012) 1.65

Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study. Lancet Neurol (2015) 1.62

Retinopathy and cognitive impairment in adults with CKD. Am J Kidney Dis (2012) 1.58

Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: preliminary evidence of axonal degeneration in the temporal lobe. AJNR Am J Neuroradiol (2007) 1.57

The apolipoprotein E epsilon 2 allele and decline in episodic memory. J Neurol Neurosurg Psychiatry (2002) 1.57

Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both. Neurology (2005) 1.52

Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med (2006) 1.52

Brain lithium levels and effects on cognition and mood in geriatric bipolar disorder: a lithium-7 magnetic resonance spectroscopy study. Am J Geriatr Psychiatry (2009) 1.50

Criterion-referenced validity of a neuropsychological test battery: equivalent performance in elderly Hispanics and non-Hispanic Whites. J Int Neuropsychol Soc (2005) 1.50

Specific subjective memory complaints in older persons may indicate poor cognitive function. J Am Geriatr Soc (2011) 1.50

Automated 3D mapping of baseline and 12-month associations between three verbal memory measures and hippocampal atrophy in 490 ADNI subjects. Neuroimage (2010) 1.45

The association of traumatic brain injury with rate of progression of cognitive and functional impairment in a population-based cohort of Alzheimer's disease: the Cache County Dementia Progression Study. Int Psychogeriatr (2014) 1.43

Automated hippocampal shape analysis predicts the onset of dementia in mild cognitive impairment. Neuroimage (2011) 1.34

Brain behavior relationships among African Americans, whites, and Hispanics. Alzheimer Dis Assoc Disord (2008) 1.30

Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old. Neurology (2006) 1.25

Short or long sleep duration is associated with memory impairment in older Chinese: the Guangzhou Biobank Cohort Study. Sleep (2011) 1.24

Mild cognitive impairment in different functional domains and incident Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.23

Heterogeneity in mild cognitive impairment: differences in neuropsychological profile and associated white matter lesion pathology. J Int Neuropsychol Soc (2009) 1.22

Telephone assessment of cognitive function in the late-onset Alzheimer's disease family study. Arch Neurol (2010) 1.22

Mild cognitive impairment in Parkinson's disease: subtypes and motor characteristics. Parkinsonism Relat Disord (2009) 1.19

Free and cued selective reminding identifies very mild dementia in primary care. Alzheimer Dis Assoc Disord (2010) 1.19

Population normative data for the 10/66 Dementia Research Group cognitive test battery from Latin America, India and China: a cross-sectional survey. BMC Neurol (2009) 1.18

KIBRA genetic polymorphism influences episodic memory in later life, but does not increase the risk of mild cognitive impairment. J Cell Mol Med (2008) 1.17

A prospective analysis of elevated fasting glucose levels and cognitive function in older people: results from PROSPER and the Rotterdam Study. Diabetes (2010) 1.17

Prevalence, distribution, and impact of mild cognitive impairment in Latin America, China, and India: a 10/66 population-based study. PLoS Med (2012) 1.15

The profile and impact of probable dementia in a sub-Saharan African community: Results from the Ibadan Study of Aging. J Psychosom Res (2006) 1.15

Neural correlates of novelty and face-age effects in young and elderly adults. Neuroimage (2008) 1.12

Limitations of the Mini-Mental State Examination for screening dementia in a community with low socioeconomic status: results from the Sao Paulo Ageing & Health Study. Eur Arch Psychiatry Clin Neurosci (2008) 1.12

Differences in brain volume, hippocampal volume, cerebrovascular risk factors, and apolipoprotein E4 among mild cognitive impairment subtypes. Arch Neurol (2009) 1.11

Rural-urban migration and depression in ageing family members left behind. Br J Psychiatry (2009) 1.09

Memory dysfunction, psychomotor slowing, and decreased executive function predict mortality in patients with heart failure and low ejection fraction. J Card Fail (2010) 1.09

Healthy ageing in the Nun Study: definition and neuropathologic correlates. Age Ageing (2007) 1.09

Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life. Brain Res (2010) 1.08

Cognitive deficits and health-related quality of life in chronic heart failure. J Cardiovasc Nurs (2010) 1.07

Musically cued gait-training improves both perceptual and motor timing in Parkinson's disease. Front Hum Neurosci (2014) 1.07

Neuropsychological strategies for detecting early dementia. J Int Neuropsychol Soc (2008) 1.06

Incidence of and risk factors for dementia in the Ibadan study of aging. J Am Geriatr Soc (2011) 1.06

Relation of hemoglobin to level of cognitive function in older persons. Neuroepidemiology (2008) 1.05

Heritability of different forms of memory in the Late Onset Alzheimer's Disease Family Study. J Alzheimers Dis (2011) 1.01

Postmenopausal hormone therapy, timing of initiation, APOE and cognitive decline. Neurobiol Aging (2010) 1.00

A randomized controlled Alzheimer's disease prevention trial's evolution into an exposure trial: the PREADViSE Trial. J Nutr Health Aging (2013) 1.00

Decline in cognitive function and risk of elder self-neglect: finding from the Chicago Health Aging Project. J Am Geriatr Soc (2010) 1.00

Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. The DESCRIPA Study. Neuroepidemiology (2008) 1.00

Nonamnestic presentations of early-onset Alzheimer's disease. Am J Alzheimers Dis Other Demen (2012) 0.99

The CERAD Neuropsychologic Battery Total Score and the progression of Alzheimer disease. Alzheimer Dis Assoc Disord (2010) 0.99

Stroke risk modifies regional white matter differences in mild cognitive impairment. Neurobiol Aging (2008) 0.99

The effect of a pre- and postoperative orthogeriatric service on cognitive function in patients with hip fracture: randomized controlled trial (Oslo Orthogeriatric Trial). BMC Med (2014) 0.99

The brain-derived neurotrophic factor Val66Met polymorphism, hippocampal volume, and cognitive function in geriatric depression. Am J Geriatr Psychiatry (2010) 0.98

How arousal affects younger and older adults' memory binding. Exp Aging Res (2011) 0.98

Executive function predicts risk of falls in older adults without balance impairment. BMC Geriatr (2011) 0.98

Combined analysis of grey matter voxel-based morphometry and white matter tract-based spatial statistics in late-life bipolar disorder. J Psychiatry Neurosci (2011) 0.98

Neuropsychological performance in advanced age: influences of demographic factors and Apolipoprotein E: findings from the Cache County Memory Study. Clin Neuropsychol (2008) 0.97

Living alone with dementia: lack of awareness adds to functional and cognitive vulnerabilities. Int Psychogeriatr (2010) 0.95

CERAD practice effects and attrition bias in a dementia prevention trial. Int Psychogeriatr (2013) 0.95

Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing & Health Study (SPAH). BMC Public Health (2010) 0.94

Loss of emotional insight in behavioral variant frontotemporal dementia or "frontal anosodiaphoria". Conscious Cogn (2011) 0.94

Posterior cortical atrophy: evidence for discrete syndromes of early-onset Alzheimer's disease. Am J Alzheimers Dis Other Demen (2011) 0.94

Extending neuropsychological assessments into the primary mental ability space. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn (2005) 0.94

The neural correlates of naming and fluency deficits in Alzheimer's disease: an FDG-PET study. Int J Geriatr Psychiatry (2009) 0.94

Auditory steady state response in bipolar disorder: relation to clinical state, cognitive performance, medication status, and substance disorders. Bipolar Disord (2010) 0.93

Spoken Language Derived Measures for Detecting Mild Cognitive Impairment. IEEE Trans Audio Speech Lang Process (2011) 0.93

A battery of tests for assessing cognitive function in older Latino persons. Alzheimer Dis Assoc Disord (2009) 0.93

Validity of the self reporting questionnaire-20 in epidemiological studies with older adults: results from the Sao Paulo Ageing & Health Study. Soc Psychiatry Psychiatr Epidemiol (2008) 0.93

Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease. J Alzheimers Dis (2006) 0.92

Effects of age, age-related hearing loss, and contralateral cafeteria noise on the discrimination of small frequency changes: psychoacoustic and electrophysiological measures. J Assoc Res Otolaryngol (2005) 0.92

Heritability of cognitive functions in families of successful cognitive aging probands from the Central Valley of Costa Rica. J Alzheimers Dis (2011) 0.91

Allosteric modulation of the M1 muscarinic acetylcholine receptor: improving cognition and a potential treatment for schizophrenia and Alzheimer's disease. Drug Discov Today (2013) 0.90

Dietary niacin and the risk of incident Alzheimer's disease and of cognitive decline. J Neurol Neurosurg Psychiatry (2004) 0.90

Early disturbances of gamma band dynamics in mild cognitive impairment. J Neural Transm (Vienna) (2010) 0.90

Effects of emotional arousal on memory binding in normal aging and Alzheimer's disease. Am J Psychol (2011) 0.90

Increased 3-hydroxykynurenine serum concentrations differentiate Alzheimer's disease patients from controls. Eur Arch Psychiatry Clin Neurosci (2012) 0.89

Hypersexual behavior in frontotemporal dementia: a comparison with early-onset Alzheimer's disease. Arch Sex Behav (2013) 0.89

Cognitive status and physical function in older african americans. J Am Geriatr Soc (2008) 0.89

Patterns of cognitive function in aging: the Rotterdam Study. Eur J Epidemiol (2014) 0.89

Impact of genetic variation in SORCS1 on memory retention. PLoS One (2011) 0.88

Hand grip strength and associated factors in non-institutionalised men and women 50 years and older in South Africa. BMC Res Notes (2014) 0.87

Monounsaturated, trans, and saturated Fatty acids and cognitive decline in women. J Am Geriatr Soc (2011) 0.87

A genome-wide survey of human short-term memory. Mol Psychiatry (2009) 0.87

Psychological wellbeing, physical impairments and rural aging in a developing country setting. Health Qual Life Outcomes (2009) 0.87

Protocol for a randomized controlled trial evaluating the effect of physical activity on delaying the progression of white matter changes on MRI in older adults with memory complaints and mild cognitive impairment: the AIBL Active trial. BMC Psychiatry (2012) 0.87

The natural history of insomnia in the Ibadan study of ageing. Sleep (2011) 0.87

Extensive metabolic and neuropsychological abnormalities associated with discrete infarction of the genu of the internal capsule. J Neurol Neurosurg Psychiatry (2001) 0.87

Determinants of quality of life of elderly Nigerians: results from the Ibadan study of ageing. Afr J Med Med Sci (2008) 0.87

Social capital and health among older adults in South Africa. BMC Geriatr (2013) 0.86

The effect of APOE-epsilon4 on dementia is mediated by Alzheimer neuropathology. Alzheimer Dis Assoc Disord (2009) 0.86

Articles by these authors

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01

Current concepts in mild cognitive impairment. Arch Neurol (2001) 18.09

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology (1989) 16.83

A new rating scale for Alzheimer's disease. Am J Psychiatry (1984) 15.16

Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol (1991) 14.25

Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46

The HNRC 500--neuropsychology of HIV infection at different disease stages. HIV Neurobehavioral Research Center. J Int Neuropsychol Soc (1995) 5.38

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med (1998) 4.43

Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology (2001) 3.74

Cerebral amyloid angiopathy in the brains of patients with Alzheimer's disease: the CERAD experience, Part XV. Neurology (1996) 3.23

Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA (1999) 3.22

Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease. Arch Neurol (1998) 3.20

Comparisons of verbal fluency tasks in the detection of dementia of the Alzheimer type. Arch Neurol (1992) 3.04

Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol (1991) 2.89

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology confirmation of the clinical diagnosis of Alzheimer's disease. Neurology (1995) 2.69

Head trauma as a risk factor for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.63

Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull (1988) 2.50

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. Am J Psychiatry (1994) 2.41

Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 2.36

Interlaboratory comparison of neuropathology assessments in Alzheimer's disease: a study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) J Neuropathol Exp Neurol (1994) 2.34

Computer-assisted interview of patients with functional headache. Arch Intern Med (1972) 2.31

Detection and staging of dementia in Alzheimer's disease. Use of the neuropsychological measures developed for the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol (1992) 2.19

Subcortical abnormalities detected in bipolar affective disorder using magnetic resonance imaging. Clinical and neuropsychological significance. Arch Gen Psychiatry (1990) 2.18

Alzheimer's disease: a study of epidemiological aspects. Ann Neurol (1984) 2.17

Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases. Neurology (1997) 2.13

The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease. Am J Psychiatry (1995) 2.11

Lymphogranuloma Venereum: A Histologic Study of the Primary Lesion, Bubonulus, and Lymph Nodes in Cases Proved by Isolation of the Virus. Am J Pathol (1947) 2.07

Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Arch Neurol (1999) 2.02

Quantitative and qualitative analyses of clock drawings in Alzheimer's and Huntington's disease. Brain Cogn (1992) 1.98

Prediction of intracerebral hemorrhage survival. Ann Neurol (1988) 1.92

Sensitivity and specificity of standardized screens of cognitive impairment and dementia among elderly black and white community residents. J Clin Epidemiol (1990) 1.90

The consortium to establish a registry for Alzheimer's disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology (1993) 1.89

Patterns of risk in first-degree relatives of patients with Alzheimer's disease. Arch Gen Psychiatry (1994) 1.84

Semantic memory impairment in Alzheimer's disease: failure of access or degraded knowledge? Neuropsychologia (1992) 1.82

The prevalence and 3-year incidence of dementia in older Black and White community residents. J Clin Epidemiol (1998) 1.82

The Alzheimer's disease assessment scale: an instrument for assessing treatment efficacy. Psychopharmacol Bull (1983) 1.81

Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias. Am J Psychiatry (1986) 1.80

Serotonergic studies in patients with affective and personality disorders. Correlates with suicidal and impulsive aggressive behavior. Arch Gen Psychiatry (1989) 1.79

Genome scan of schizophrenia. Am J Psychiatry (1998) 1.74

Reduced cerebral grey matter observed in alcoholics using magnetic resonance imaging. Alcohol Clin Exp Res (1991) 1.71

Risk due to inactivity in physically capable older adults. Am J Public Health (1993) 1.69

The pilot Stroke Data Bank: definition, design, and data. Stroke (1984) 1.67

Dementia in institutionalized elderly: relation to sleep apnea. J Am Geriatr Soc (1991) 1.67

Impaired prepulse inhibition of acoustic and tactile startle response in patients with Huntington's disease. J Neurol Neurosurg Psychiatry (1995) 1.64

Neuropeptide abnormalities in patients with early Alzheimer disease. Arch Gen Psychiatry (1999) 1.62

Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. Am J Psychiatry (1998) 1.60

Weight change in Alzheimer's disease. J Am Geriatr Soc (1996) 1.57

Differential patterns of memory loss among patients with Alzheimer's disease, Huntington's disease, and alcoholic Korsakoff's syndrome. Arch Neurol (1986) 1.54

The CERAD experience, Part VIII: Neuroimaging-neuropathology correlates of temporal lobe changes in Alzheimer's disease. Neurology (1995) 1.51

Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia. Arch Gen Psychiatry (1997) 1.51

Cerebrovascular disease in the bi-racial population of Evans County, Georgia. Stroke (1974) 1.50

The role of oral contraceptive agents in cerebral arterial occlusion. Neurology (1969) 1.47

Some connections of the entorhinal (area 28) and perirhinal (area 35) cortices of the rhesus monkey. II. Frontal lobe afferents. Brain Res (1975) 1.47

The longitudinal stability of cognitive impairment in schizophrenia. Mini-mental state scores at one- and two-year follow-ups in geriatric in-patients. Br J Psychiatry (1995) 1.46

Neuropsychological evidence for multiple implicit memory systems: a comparison of Alzheimer's, Huntington's, and Parkinson's disease patients. J Neurosci (1989) 1.46

Increased pressure for rapid eye movement sleep at time of hospital admission predicts relapse in nondepressed patients with primary alcoholism at 3-month follow-up. Arch Gen Psychiatry (1994) 1.45

Deterioration on the Blessed test in Alzheimer's disease: longitudinal data and their implications for clinical trials and identification of subtypes. Psychiatry Res (1992) 1.45

Cortical afferents to the entorhinal cortex of the Rhesus monkey. Science (1972) 1.45

Variability in annual Mini-Mental State Examination score in patients with probable Alzheimer disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's Disease. Arch Neurol (1999) 1.43

Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults. Neurology (1995) 1.42

Estimated prevalence of dementia among elderly black and white community residents. Arch Neurol (1991) 1.39

Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations. Neurology (1990) 1.38

Relationship of health and demographic characteristics to Mini-Mental State examination score among community residents. Psychol Med (1988) 1.37

Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biol Psychiatry (1999) 1.36

Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn (1996) 1.36

Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol (2000) 1.35

Psychiatric history and related exposures as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol (1991) 1.33

Cerebral structure on MRI, Part II: Specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry (1991) 1.32

Familial aggregation in Alzheimer's disease: comparison of risk among relatives of early-and late-onset cases, and among male and female relatives in successive generations. Neurology (1988) 1.32

Impaired learning of a motor skill in patients with Huntington's disease. Behav Neurosci (1988) 1.32

The consortium to establish a registry for Alzheimer's disease (CERAD). Part XIV: Demographic and clinical predictors of survival in patients with Alzheimer's disease. Neurology (1996) 1.28

Evidence of presymptomatic cognitive decline in Huntington's disease. J Clin Exp Neuropsychol (1992) 1.27

Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology (1998) 1.26

Association of education with incidence of cognitive impairment in three established populations for epidemiologic studies of the elderly. J Clin Epidemiol (1994) 1.23

Effect of parietal lobe damage on the performance of reversible operations in space. Neuropsychologia (1970) 1.23

Cognitive loss and recovery in long-term alcohol abusers. Arch Gen Psychiatry (1983) 1.23

Risk of stroke in asymptomatic persons with cervical arterial bruits: a population study in Evans County, Georgia. N Engl J Med (1980) 1.22

Risk of ischemic heart disease in patients with TIA. Neurology (1984) 1.21

Cortisol and Alzheimer's disease, I: Basal studies. Am J Psychiatry (1986) 1.20

Dimensionality and clustering in the semantic network of patients with Alzheimer's disease. Psychol Aging (1993) 1.20

Familial aggregation of Alzheimer's disease and related disorders: a collaborative re-analysis of case-control studies. Int J Epidemiol (1991) 1.20

Are all subcortical dementias alike? Verbal learning and memory in Parkinson's and Huntington's disease patients. J Clin Exp Neuropsychol (1990) 1.20

Verbal memory performance of patients with human immunodeficiency virus infection: evidence of subcortical dysfunction. The HNRC Group. J Clin Exp Neuropsychol (1994) 1.20

Neurobiology of skill and habit learning. Curr Opin Neurobiol (1995) 1.20

Magnetic resonance imaging of alcoholic Korsakoff patients. Neuropsychopharmacology (1991) 1.19

Clinical validity of the Mattis Dementia Rating Scale in detecting Dementia of the Alzheimer type. A double cross-validation and application to a community-dwelling sample. Arch Neurol (1995) 1.18

Volumetric magnetic resonance imaging quantification of longitudinal brain changes in abstinent alcoholics. Alcohol Clin Exp Res (1994) 1.17

Transient cerebral ischemia. Prevalence and prognosis in a biracial rural community. JAMA (1973) 1.17

Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch Neurol (2001) 1.17

Physostigmine: improvement of long-term memory processes in normal humans. Science (1978) 1.16